The ConferenceThe Conference
Overview
Valvular heart disease affects a large number of people who require diagnostic procedures and long-term management. Valve problems can be present at birth or caused by infections, heart attacks, or heart disease and damage. Some valve problems are minor and do not need treatment. Others might require medical management of symptoms or therapy to repair or replace the diseased valve. Many patients have no symptoms, but for others, if not treated, advanced heart valve disease can cause heart failure, stroke, blood clots, or death due to sudden cardiac arrest.
CME Accreditation and Designation
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this live activity for a maximum of 37.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Left Atrial Appendage (LAA) Session
Left atrial appendage (LAA) is the primary nonvalvular cause of thromboembolic stroke in patients with atrial fibrillation (A-fib). The spectrum of treatment involves oral anticoagulants, ablation, surgery, and catheter-based approaches.
Attend the LAA Session at TVT 2013 to learn about anatomy, imaging, techniques, and the future of LAA occlusion and closure at this special, focused session with the pioneers and thought leaders in the field of transcatheter valve therapies.
Focus on the Heart Team Breakout Sessions
This year at TVT we are offering focused breakout sessions for the entire heart team. These sessions will cover the best practices and new approaches for TAVR program clinical operations, as well as challenges for TAVR program growth.
View the agenda below to learn more about these unique sessions.
